close

Enter

Log in using OpenID

Prescription Narcotic Cough Preparations and Expectorants Market: Incur Rapid Extension During 2018 – 2026

embed
Narcotic preparations are medicines that primarily induce sleep. The basic three narcotics are morphine, codeine, and thebaine. Mucokinetics are drugs that clear mucus from the lungs, airways, trachea, and bronchi. Mucokinetics can be divided into e
Prescription Narcotic Cough Preparations and
Expectorants Market Advancements to Watch Out
For 2026
Prescription Narcotic Cough Preparations and Expectorants Market – Global
Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Narcotic preparations are medicines that primarily induce sleep. The basic three narcotics are
morphine, codeine, and thebaine. Mucokinetics are drugs that clear mucus from the lungs, airways,
trachea, and bronchi. Mucokinetics can be divided into expectorants, mucolytic agents, and surfactants.
Expectorant signals the body to amplify the quantity or hydration of secretions, thereby resulting into
clearer secretions. As a byproduct, expectorant lubricates the respiratory tract. Guaifenesin, an
expectorant is commonly used in many cough syrups.
The term ‘expectorant’ is often extended to all cough medicines, as it is a universal constituent. Cough
is an abrupt and frequently occurring involuntary or voluntary reflex of our body in order to clear any
unfamiliar material from the respiratory tract. Recurrent coughing is often associated with a variety of
respiratory diseases, microbial infections, and chronic obstructive pulmonary diseases (COPD).
Coughing is a communicable disease which gets transmitted through bacteria and viruses to the
unaffected person. Cough medicines are medicines that are used during coughing and related
conditions. Prescription narcotic cough preparations and expectorants are cough medicines that are
narcotic in nature, and are supposed to be consumed only when prescribed by a physician.
Request For Sample Copy of This Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/149
Narcotic drugs such as codeine, tussiden, hydrocodone, dihydrocodeine, hydromorphone, duraganidin,
Hydrostat, Guaifenesin, and Cheratussin, are some of the brands suggested for cough treatment.
Narcotic drugs primarily target the nervous system and may have severe side effects. Therefore, drugs
are generally not prescribed to children below the age of 6 years. According to a report published in
CNN Health in 2014, more than 8 billion codeine prescriptions are written in the U.S. each year.
Narcotics may have side effects such as vomiting, rashes, allergy and constipation. Elevated
occurrences of diseases and allergies will drive the future growth of the prescription narcotic cough
preparations and expectorants market.
According to a report by National Center for Biotechnology Information, acute cough comes under top
five complications of general practice. Acute cough or acute bronchitis is the fifth most frequent
presentation in Australia and the U.S. Moreover, the report also suggests that in the U.K. almost 50
persons out of 100 suffer from acute cough. Moreover, acute cough results into to 10 ambulatory visits
per 1000 patient, in the U.S. each year. Substantiation from general practice intelligence and the U.K.
and U.S. morbidity surveys demonstrate that the cases of acute cough are increasing at an alarming
rate. Therefore, the overall prescription narcotic cough preparations and expectorants market is
expected to grow proportionately.
Major manufacturers in the market compete on the basis of price, and technology (research and
development activities). Some of the major players operating in the prescription narcotic cough
preparations and expectorants market are Glenmark Pharmaceuticals Ltd., Franklin Laboratories Pvt.
Ltd., Pans Laboratories, Synokem Pharmaceuticals Ltd., Lyka Hetero Healthcare Limited, Biomedica
International, Klar Sehen Pvt. Ltd., and Ciron Drugs & Pharmaceuticals Pvt. Ltd.
Rising incidences of pertussis will drive the overall prescription narcotic cough preparations and
expectorants market
Pertussis or whooping cough is a respiratory disease which is highly contagious in nature.
Uncontrollable and violent coughing can lead to death in extreme conditions. According to Centers for
Disease Control and Prevention report, in 2014, 32,971 cases of whooping cough were reported. This is
a 15% increase as compared 28,639 cases reported in 2013. The increased rate of pertussis was
observed mostly in the adolescents (13 to 15 years). Pertussis is a condition that needs physician’s
advice for treatment, thereby increasing the demand for Prescription Narcotic Cough Preparations
and Expectorants Market.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
Author
ravikiran
ravikiran298   documents Email
Document
Category
Health and Medicine
Views
2
File Size
363 KB
Tags
cough
1/--pages
Report inappropriate content